Showing results (461-470 of 506) with videos related to
Sort By:
Pageof 51
Contemporary Clinical Trials|December 13, 2021
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 daysErin K McCreary, J Ryan Bariola, Tami Minnier, et al.JAMA Network Open|April 12, 2022
Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19Erin K McCreary, J Ryan Bariola, Richard J Wadas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care UnitsMarcio Soares, Fernando A Bozza, Luciano C P Azevedo, et al.Intensive Care Medicine|October 10, 2019
ICU staffing feature phenotypes and their relationship with patients' outcomes: an unsupervised machine learning analysisFernando G Zampieri, Jorge I F Salluh, Luciano C P Azevedo, et al.The New England Journal of Medicine|May 22, 2018
Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract InfectionDavid T Huang, Donald M Yealy, Michael R Filbin, et al.JAMA|March 21, 2013
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trialSteven M Opal, Pierre-Francois Laterre, Bruno Francois, et al.Critical Care (London, England)|December 7, 2017
Recovery after critical illness: putting the puzzle together-a consensus of 29Elie Azoulay, Jean-Louis Vincent, Derek C Angus, et al.Journal of Pain and Symptom Management|May 20, 2022
ProPACC: Protocol for a Trial of Integrated Specialty Palliative Care for Critically Ill Older AdultsSarah K Andersen, Grace Vincent, Rachel A Butler, et al.American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses|October 28, 2021
Characteristics and Outcomes of US Patients Hospitalized With COVID-19Ithan D Peltan, Ellen Caldwell, Andrew J Admon, et al.The Journal of Infectious Diseases|November 16, 2023
Prospective Assessment of Humoral and Cellular Immune Responses to a Third COVID-19 mRNA Vaccine Dose Among Immunocompromised IndividualsGhady Haidar, Jacob C Hodges, Andrew Bilderback, et al.Pageof 51